<a href="https://laohu8.com/S/CATX">Perspective Therapeutics</a> Updates Executive Compensation and Change-in-Control Terms
Perspective Therapeutics Inc. has entered into amended and restated employment agreements with Chief Executive Officer Johan (Thijs) Spoor, Chief Accounting Officer Jonathan Hunt, and Chief Medical Officer Dr. Markus Puhlmann. The updated agreements set annual base salaries at $680,000 for Mr. Spoor, $451,500 for Mr. Hunt, and $516,700 for Dr. Puhlmann. In the event of termination without cause or resignation for good reason during a period beginning three months before and ending 12 months after a change in control, executives will receive severance pay equal to 12 months of salary (18 months for Mr. Spoor), a pro-rated annual bonus, an additional annual bonus payment (1.5 times for Mr. Spoor), and up to 12 months of COBRA health coverage (18 months for Mr. Spoor). The agreements also provide for accelerated vesting of equity awards under certain conditions related to a change in control.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perspective Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-262636), on November 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.